This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Hang on a second…

This CME Activity has expired and is no longer available for credit.

Bringing Health Care Providers Together to Diagnose and Treat Idiopathic Pulmonary Fibrosis: A Patient Simulation

Bringing Health Care Providers Together to Diagnose and Treat Idiopathic Pulmonary Fibrosis: A Patient Simulation

Format

Patient Case Simulations

Time to Complete

1 hour

Released

July 18, 2017

Expires

July 18, 2018
Add to Queue


IMPORTANT NOTE—PLEASE READ

This patient simulation is not compatible with Internet Explorer. Please use a different browser (eg, Chrome, Firefox, Safari) to view the activity's content.

Maximum Credits

1.00 / AMA PRA Category 1 Credit(s)TM
1.00 / CE for Nurses (1.00 pharmacotherapeutic credit)
1.00 / CE for Pharmacists (0.10 CEUs)

Accredited Provider


This educational initiative is provided by CME Outfitters.

Commercial Supporter

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Supported by an educational grant from Genentech.

Program Description

Although the most common of the restrictive lung diseases, idiopathic pulmonary fibrosis (IPF) is a rare but deadly disease, affecting an estimated 6.8 to 42.7 per 100,000 people, with higher rates in those older than 65 years, and resulting in approximately 40,000 deaths annually in the United States.1

Education to community pulmonologists, radiologists, and primary care physicians, as well as the multidisciplinary team is important to increase knowledge related to recognition and diagnosis. Clinicians need to be aware of when to refer patients with potential IPF to specialty centers with pulmonologists, radiologists, and pathologists specialized in interstitial lung disease (ILD). All providers in the multidisciplinary and multispecialty treatment team need education related to recent ATS/ERS/JRS/ALAT guidelines and mechanisms of action for the approved treatments for IPF.

In this CME Outfitters decision-tree medical simulation participants will navigate the clinical challenges presented by a patient with IPF. Expert faculty will highlight the latest evidence and guidelines for IPF including when to refer and best treatment approach.
_________________________

Reference
1. Raghu G, Chen SY, Yeh WS, et al. Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11. Lancet Respir Med. 2014;2(7):566-572.

Intended Audience

Pulmonologists, radiologists, primary care physicians, physician assistants, nurse practitioners, nurses, pharmacists, and other healthcare providers interested in idiopathic pulmonary fibrosis

Educational Objectives

At the end of this CME/CE activity, participants should be able to:

  • Identify the signs and symptoms of idiopathic pulmonary fibrosis
  • Outline the red flags that would trigger an expeditious referral of a patient with dyspnea to a multidisciplinary team
  • Combine information derived from guidelines and studies of newly approved and emerging therapies in identifying a treatment approach for the patient with IPF

Conflict Of Interest Disclosure Policy

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Faculty

Steven D. Nathan, MD, FCCP
Medical Director, Lung Transplant Program
Director, Advanced Lung Disease Program
Inova Fairfax Hospital
Professor of Medicine
Virginia Commonwealth University, Inova Fairfax Campus
Falls Church, VA

Dr. Nathan has disclosed that he receives research support from Boehringer Ingelheim Pharmaceuticals, Inc.; Genentech, Inc./Roche. He is a member of the speakers bureau for Boehringer Ingelheim Pharmaceuticals, Inc.; Genentech, Inc./Roche. He is a consultant for Boehringer Ingelheim Pharmaceuticals, Inc.; Genentech, Inc./Roche.

Jonathan H. Chung, MD
Associate Professor of Radiology
Associate Section Chief, Thoracic Radiology
Director of Thoracic Quality Assurance
The University of Chicago Medicine
Chicago, IL

Dr. Chung has no disclosures to report.

Marilyn K. Glassberg, MD
Professor of Medicine, Surgery, and Pediatrics
Director, Interstitial Lung Disease Program
Chief, Pulmonary Division at Interdisciplinary Stem Cell Institute
Vice-Chairman of Medicine for Diversity and Innovation
Department of Medicine
University of Miami Miller School of Medicine
Miami, FL

Dr. Glassberg has disclosed that he receives research support from Genentech, Inc. She is a consultant for Boehringer Ingelheim Pharmaceuticals, Inc.; Genentech, Inc.; and Patara Pharma.

Accredited Provider Disclosure

The CME Outfitters, LLC staff has nothing to disclose.

Planners' and Managers' Disclosures

Daniela V. DiBiase, MS (peer reviewer) has no disclosures to report.
Jeffrey Helfand, DO, MS (peer reviewer) has no disclosures to report.
Kimberley Murray, RN, MS (peer reviewer) has no disclosures to report.
Jan Perez, CHCP (planning committee) has no disclosures to report.
Sharon Tordoff, CHCP (planning committee) has no disclosures to report.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

CME Outfitters, LLC, designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.00

Type

CE for Nurses

Accreditation Statement

CME Outfitters, LLC, is approved by the California Board of Registered Nursing

Designation Statement

This program is approved for a maximum of 1.00 contact hour. Provider Number CEP 15510.

Note to Nurse Practitioners and Clinical Nurse Specialists: the content of this activity pertains to pharmacology. Earn up to 1.00 contact hour of pharmacotherapeutic contact hours.

Credit

1.00

Type

CE for Pharmacists

Accreditation Statement

CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.00 contact hour (0.10 CEUs)

Universal Activity Number: 0376-0000-17-032-H01-P

Activity Type: application

Additional Credit Information

Note to Nurse Practitioners: Nurse practitioners can apply for AMA PRA Category 1 CreditTM   through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit(s)TM   from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Note to Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM   from organizations accredited by the Accreditation Council for Continuing Medical Education.

Disclosure of Unlabeled Use

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.


Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Instructions

There are no fees for participating in this CME/CE activity. To receive credit, participants must (1) read the learning objectives and disclosure statements, (2) study the educational activity, and (3) complete the post-test and activity evaluation form, including the certificate information section.

To obtain a certificate, participants must receive a score of 75% or better on the post-test. The post-test can be accessed at the end of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

If you have any questions relating to the accreditation of this activity, please contact info@cmeoutfitters.com.

If you have any other questions relating to your certificate or other issues with this activity, please contact myCME.Support@haymarketmedical.com.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue